Übersetzung für "Frozen plasma" in Deutsch

Fresh frozen human citrated plasma was thawed, the cryoprecipitate forming was separated.

Frozen blood plasma is largely insensitive to mechanical influences.

For DIC or other coagulopathies fresh frozen plasma can be given.

The initiation of appropriate treatment, e. g. surgical haemostasis or the transfusion of fresh frozen plasma should be considered.

In an emergency, fresh frozen blood plasma, which also contains C1-INH, can also be used.

Subsequently, purified fibrinogen is administered, which entails a lower risk of infection than fresh frozen plasma.

Transfusion of cryoprecipitate, fresh frozen plasma, and platelets should be considered with clinical and laboratory reassessment after each administration.

Major concern- LoOI - Q1: The Applicant was requested to submit the documentation of long-term stability of frozen plasma in order to fully document the accuracy of laboratory evaluations.

If blood products (whole blood, packed red cells, platelet concentrate and fresh frozen plasma) and hydroxocobalamin are administered simultaneously, use of separate intravenous lines (preferably on contralateral extremities) is recommended.

Simultaneous administration of hydroxocobalamin and blood products (whole blood, packed red cells, platelet concentrate and fresh frozen plasma) through the same intravenous line is not recommended.

Simultaneous administration of hydroxocobalamin and blood products (whole blood, packed red cells, platelet concentrate and fresh frozen plasma) through the same intravenous line is not recommended (see section 6.6).

If blood products (whole blood, packed red cells, platelet concentrate and fresh frozen plasma) and hydroxocobalamin are administered simultaneously, use of separate intravenous lines (preferably on contralateral extremities) is recommended (see section 6.2).

Appropriate symptomatic treatment could be used as needed, such as mechanical compression (e.g. for severe epistaxis), surgical haemostasis with bleeding control procedures, fluid replacement and haemodynamic support, blood products (packed red cells or fresh frozen plasma, depending on associated anaemia or coagulopathy) or platelets.

Pro-coagulant factor treatments (e.g., 3- or 4-factor prothrombin complex concentrate (PCC)/activated PCC, recombinant factor VIIa, fresh frozen plasma) and whole blood should be avoided unless absolutely required, due to lack of data in combination with these treatments.

The content of albumin and immunoglobulins is comparable with fresh frozen plasma, factor VIII, von Willebrand factor, fibrinogen, factor XIII and fibronectin are reduced;

In the undertaken study, the participating countries were asked whether they have experienced regular shortage of blood and blood components, and in particular for whole blood, fresh frozen plasma (for transfusion), red blood cells, white blood cells, platelets and plasma fractions, such as immunoglobulin, factor VIII, factor IX, albumin, lipoprotein, fibrinogen and antithrombine III (Figure V).

Transfusions of cryoprecipitate, fibrinogen, fresh frozen plasma and platelets should be considered with clinical and laboratory reassessment after each administration.

For adults and paediatric aHUS patients supplemental dosing of Soliris is required in the setting of concomitant PE/PI (plasmapheresis or plasma exchange, or fresh frozen plasma infusion):

The initiation of appropriate treatment, e.g., surgical haemostasis or the transfusion of fresh frozen plasma should be considered.